DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Fizazi K, Carducci M, Smith M. et al.
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study.
Lancet 2011;
377 (97/68) 813-822
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.